Tailored therapy in patients treated with fluoropyrimidines: focus on the role of dihydropyrimidine dehydrogenase

Fluoropyrimidines are widely used in the treatment of solid tumors, mainly gastrointestinal, head and neck and breast cancer. Dihydropyrimidine dehydrogenase (DPD) is the rate-limiting enzyme for catabolism of 5-FU and it is encoded by DPYD gene. To date, many known polymorphisms cause DPD deficienc...

Descripción completa

Detalles Bibliográficos
Autores principales: Merloni, Filippo, Ranallo, Nicoletta, Scortichini, Laura, Giampieri, Riccardo, Berardi, Rossana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992529/
https://www.ncbi.nlm.nih.gov/pubmed/35582578
http://dx.doi.org/10.20517/cdr.2018.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992529/
https://www.ncbi.nlm.nih.gov/pubmed/35582578
http://dx.doi.org/10.20517/cdr.2018.006

Ejemplares similares